This inventor holds 1 USPTO granted patent. Top assignee: Rapid Medical Diagnostic Corporation. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Michael D Grant: Innovator in Hepatitis C Diagnosis and Therapy
Introduction
Michael D Grant is a notable inventor based in St. John's, Canada. He has made significant contributions to the field of medical diagnostics and therapy, particularly concerning Hepatitis C Virus (HCV) related diseases. His innovative work has led to the development of a unique antibody that plays a crucial role in diagnosing and treating HCV infections.
Latest Patents
Michael D Grant holds a patent for an "Anti-idiotypic antibody and its use in diagnosis and therapy of Hepatitis C Virus related diseases." This invention provides methods for the diagnosis, prognosis, and treatment of HCV-related diseases. The method utilizes a novel reactive mechanism of the murine monoclonal antibody (mAb) 1F7, which targets human antibodies specific to various proteins of the Hepatitis C Virus and Human Immunodeficiency Virus (HIV). The antibody 1F7 is capable of recognizing antibodies against HCV core protein in a majority of HCV-infected individuals, as well as antibodies against HCV non-structural proteins 3 (NS3) and NS4 in some cases. Additionally, it recognizes antibodies against the principal neutralizing determinant of HCV. This antibody can be formulated with physiologically acceptable carriers to create various compositions for treating HCV infections.
Career Highlights
Michael D Grant is associated with Rapid Medical Diagnostic Corporation, where he continues to advance his research and development efforts. His work has been instrumental in enhancing the understanding and treatment of HCV-related diseases, showcasing his commitment to improving public health through innovative solutions.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Michael D Grant's contributions to the field of medical diagnostics and therapy highlight the importance of innovation in combating viral diseases. His patented work on the anti-idiotypic antibody represents a significant advancement in the diagnosis and treatment of Hepatitis C Virus related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile